Movement Disorders (revue) - Curation (Ncbi)

Index « Mesh.i » - entrée « Genetic Therapy »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Genetic Testing < Genetic Therapy < Genetic Variation  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000184 (2000) D S Latchman [Royaume-Uni] ; R S CoffinViral vectors in the treatment of Parkinson's disease.
000975 (2003) Jay S. Schneider [États-Unis] ; Timothy V. WadeExperimental parkinsonism is associated with increased pallidal GAD gene expression and is reversed by site-directed antisense gene therapy.
001B47 (2007) Andrew Feigin [États-Unis] ; David EidelbergGene transfer therapy for neurodegenerative disorders.
001E72 (2008) Samuel A. Frank [États-Unis] ; Renee Wilson ; Robert G. Holloway ; Carol Zimmerman ; Derick R. Peterson ; Karl Kieburtz ; Scott Y H. KimEthics of sham surgery: perspective of patients.
002872 (2009) Shigeki Hirano [États-Unis] ; Thomas Eckert [États-Unis, Allemagne] ; Toni Flanagan [États-Unis] ; David Eidelberg [États-Unis]Metabolic Networks for Assessment of Therapy and Diagnosis in Parkinson’s Disease
002A68 (2010) Tomas Bjorklund [Suède] ; Jeffrey H. KordowerGene therapy for Parkinson's disease.
002F75 (2010) Travis B. Lewis [États-Unis] ; David G. Standaert [États-Unis]Parkinson Disease, Primates, and Gene Therapy: Vive la Différence?
002F79 (2011) Raymond T. Bartus [États-Unis] ; Christopher D. Herzog ; Yaping Chu ; Alistair Wilson ; Lamar Brown ; Joao Siffert ; Eugene M. Johnson ; C Warren Olanow ; Elliott J. Mufson ; Jeffrey H. KordowerBioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains.
003922 (2013) Lorraine V. Kalia [Canada] ; Jonathan M. Brotchie ; Susan H. FoxNovel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials.
003A08 (2013) Jeffrey H. Kordower [États-Unis] ; Anders BjorklundTrophic factor gene therapy for Parkinson's disease.
004089 (2014) James F. Gusella [États-Unis] ; Marcy E. Macdonald ; Jong-Min LeeGenetic modifiers of Huntington's disease.
004092 (2014) Edward J. Wild ; Sarah J. TabriziTargets for future clinical trials in Huntington's disease: What's in the pipeline?
004197 (2015) Nathan C. Rowland [États-Unis] ; Philip A. Starr ; Paul S. Larson ; Jill L. Ostrem ; William J. Marks ; Daniel A. LimCombining cell transplants or gene therapy with deep brain stimulation for Parkinson's disease.
004B91 (1996) A. Freese [États-Unis] ; M. Stern ; M G Kaplitt ; W M O'Connor ; M V Abbey ; M J O'Connor ; M J DuringProspects for gene therapy in Parkinson's disease.
004F43 (1998) U J Kang [États-Unis]Potential of gene therapy for Parkinson's disease: neurobiologic issues and new developments in gene transfer methodologies.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Genetic Therapy" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Genetic Therapy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Genetic Therapy
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024